Alison Stevenson, Managing Director and Head of R&D at Tor-Bac, explains why this single-dose product has experienced year-on-year sales growth since its introduction to the UK market in 2018. Stevenson explains: “Practitioners offering injectable procedures are familiar with using bacteriostatic …
Treating Vascular Occlusion in the Chin
July 14, 2026